Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $2,200.00 |
|---|---|
| Enterprise Value | $895,453.00 |
| Earnings per Share | $-0.04 |
| Beta | -2.58 |
| Outstanding Shares | 13,649,254 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.04 |
| Enterprise Value to EBIT | -0.32 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.02 |
| Debt to Equity | 3.99 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Applied Biosciences Corp. is dedicated to the creation and market launch of synthetic cannabinoid biopharmaceutical treatments. These advanced therapeutics are specifically designed to interact with the body's endocannabinoid system, aim...